Funding¶
| Analytical BioSciences and Metabolomics, Division of Systems Biomedicine and Pharmacology, Leiden University. |
| European Union’s Horizon 2020 research and innovation programme under grant agreement No 668738. |
| U.S. Department of Energy, Offices of Advanced Scientific Computing Research and the Biological and Environmental Research as part of the Scientific Discovery Through Advanced Computing program, grant no. DE-SC0010429 |
| This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 757922)” |
| This project has received funding from the Open Multiscale Systems Medicine (OpenMultiMed), a COST (European Cooperation in Science and Technology) Action, under the European Union’s Framework Programme Horizon 2020 research and innovation programme (Grant agreement no. CA15120)” |
Nathan E. Lewis has been supported by NIGMS (R35 GM119850) and the Novo Nordisk Foundation (NNF10CC1016517). Anne Richelle has been supported by the Lilly Innovation Fellows Award.




